ProCore Bio Med Ltd. is a member of two consortiums in this prestigious program:
- ADIPOA – A stem cell therapy-based project for degenerative joint diseases. ProCore is a leading SME partner in this consortium and contributes its knowledge in stem and progenitor cell therapies.
- NPMimetic – A biomaterial oriented project for development of innovative solutions to Degenerative Disc Disease. ProCore is a major partner in this consortium and uses its experience to develop biocompatible hydrogels and bioactive molecules.
ProCore has been a principal member of the “Genesis” consortium, the Israeli consortium for stem cells therapy. This unique six year funded consortium consists of leading stem cell companies and key scientists in the field of adult and embryonic stem cell-based therapy.
Procore was acknowledged for its contribution to the consortium, allowing access to its proprietary set of FGF variants, as well as its unique stem cell platform and for the development of a novel antibody microarray for stem cell characterization.
List of the Israeli winners in the EU 7th Framework Programme (click here).